Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Menopausal Vasomotor Symptoms and Biological Aging in Obese Post-menopausal Women
NCT07218445Phase 4Recruiting
- Sponsor
- Mayo Clinic
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide, sponsored by Mayo Clinic. Started Apr 2026; status: recruiting.
02
Drugs
Beyond the preview
Go deeper on NCT07218445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218445.